RHUMBLINE ADVISERS - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$219,000
-62.1%
43,959
-3.8%
0.00%
-100.0%
Q4 2020$578,000
+49.0%
45,719
+15.7%
0.00%0.0%
Q3 2020$388,000
-14.9%
39,506
-13.8%
0.00%0.0%
Q2 2020$456,000
+27.7%
45,815
+13.5%
0.00%0.0%
Q1 2020$357,000
+13.3%
40,349
+18.0%
0.00%0.0%
Q4 2019$315,000
+57.5%
34,194
+0.6%
0.00%
Q3 2019$200,000
-46.2%
33,984
+9.7%
0.00%
-100.0%
Q2 2019$372,000
+0.3%
30,986
+0.8%
0.00%0.0%
Q1 2019$371,000
-5.4%
30,743
-1.7%
0.00%0.0%
Q4 2018$392,000
+20.2%
31,261
+42.4%
0.00%0.0%
Q3 2018$326,000
-10.4%
21,948
+1.4%
0.00%0.0%
Q2 2018$364,000
-9.2%
21,637
+23.5%
0.00%0.0%
Q1 2018$401,000
-10.1%
17,513
+1.5%
0.00%0.0%
Q4 2017$446,000
+47.7%
17,248
-15.6%
0.00%0.0%
Q3 2017$302,000
+6.7%
20,448
+1.0%
0.00%0.0%
Q2 2017$283,000
-11.6%
20,253
+8.0%
0.00%0.0%
Q1 2017$320,000
+74.9%
18,753
+5.5%
0.00%
Q4 2016$183,000
+3.4%
17,777
+1.8%
0.00%
Q3 2016$177,000
-8.8%
17,458
+1.2%
0.00%
-100.0%
Q2 2016$194,000
-4.4%
17,248
+16.3%
0.00%0.0%
Q1 2016$203,000
-27.2%
14,834
+0.8%
0.00%0.0%
Q4 2015$279,000
+8.1%
14,709
+6.9%
0.00%0.0%
Q3 2015$258,000
+31.6%
13,754
+4.4%
0.00%0.0%
Q2 2015$196,00013,1800.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 2,610$620,000,0006.47%
Parkman Healthcare Partners LLC 1,124,072$4,732,0001.74%
Kynam Capital Management, LP 1,000,000$4,210,0001.08%
EAM Investors, LLC 850,647$3,581,0000.87%
BVF INC/IL 3,629,000$15,278,0000.74%
EAM Global Investors LLC 388,730$1,637,0000.40%
RA Capital Management 3,307,203$13,923,0000.37%
Nantahala Capital Management 1,659,840$6,988,0000.35%
AWM Investment Company, Inc. 504,661$2,125,0000.34%
INGALLS & SNYDER LLC 1,411,153$5,941,0000.31%
View complete list of CONCERT PHARMACEUTICALS INC shareholders